Loading...

Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome

AIM: This study sought to clarify the usefulness of lenvatinib for patients with unresectable hepatocellular carcinoma (HCC). METHODS: The subjects were 69 patients with HCC receiving lenvatinib; the median age was 73 years, and 14 and 67 patients had been previously treated with regorafenib and/or...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: Fuchigami, Akira, Imai, Yukinori, Uchida, Yoshihito, Uchiya, Hiroshi, Fujii, Yohei, Nakazawa, Manabu, Ando, Satsuki, Sugawara, Kayoko, Nakayama, Nobuaki, Tomiya, Tomoaki, Mochida, Satoshi
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7147769/
https://ncbi.nlm.nih.gov/pubmed/32275701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0231427
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!